FLASCO

 

Corporate Members

Diamond Elite

Diamond

Platinum

Gold

Silver

Latest News

FLASCO Prior Authorization Webinar

On April 17th, FLASCO’s Administrator Network hosted a webinar to discuss the challenges faced by practices when dealing with Prior Authorizations. We were joined by Risë Cleland, who presented Practical Strategies: The Challenge of Prior Authorization Burdens . Following Risë’s presentation, a panel representing different types of oncology practices in Florida, provided further insight on the topic. ...

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) + Yervoy® (ipilimumab) Combination as First-Line Treatment for Patients with Intermediate- and Poor-Risk Advanced Renal Cell Carcinoma

 The Opdivo + low-dose Yervoy combination is the first and only treatment to show significantly superior overall survival versus sunitinib in intermediate- and poor-risk advanced renal cell carcinoma, including a survival benefit regardless of PD-L1 expression 1,2 Treatment with Opdivo + Yervoy delivered higher objective response rates, including more complete responses, than sunitinib 1,2 In the CheckMate -214 trial, which used dosing optimized for advanced renal...

FDA approves nivolumab plus ipilimumab combination for intermediate or poor-risk advanced renal cell carcinoma

On April 16, 2018, the Food and Drug Administration granted approvals to nivolumab and ipilimumab (Opdivo and Yervoy, Bristol-Myers Squibb Co.) in combination for the treatment of intermediate or poor risk, previously untreated advanced renal cell carcinoma. The approvals were based on CheckMate 214 (NCT02231749), a randomized open-label trial. Patients with previously untreated advanced RCC...

FCS Foundation Honors Founding Chair Brad Prechtl and Announces New Board Leadership

Sarasota, FL – April 11th, 2018… The Florida Cancer Specialists (FCS) Foundation Board is pleased to announce new Board Co-Chairs, Dr. Michael Diaz, and FCS Board Member Jeffrey Phipps, Sr., as well as welcome new board member, FCS Physician Dr. Maen Hussein. Founding Chair, Brad Prechtl, was honored for his remarkable service to the Board and his contributions to the FCS...

FLASCO Fellow: Making a Difference in Patient’s Lives

As a senior fellow, one is blessed to have a light call schedule compared with that of our younger peers. Having paid our dues during residency and fellowship, we get the privilege of picking our call schedules and are required to cover just 4 weekends for the whole year. With 3 call weekends left on...

Who’s Online

Profile picture of Julie Newberry